Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Takaaki Ono
Observed names:
T Ono,
T. Ono,
Taka-aki Ono,
Takaaki ONO
Institutions:
Hamamatsu University,
Hamamatsu University School of Medicine,
Hamamatsu University Hospital
Observed institutions:
Jikei University School of Medicine,
Hamamatsu University,
Fujisawa City Hospital,
Hamamatsu University School of Medicine,
Hamamatsu University Hospital,
Seirei Hamamatsu General Hospital
show all 6
ORCID:
0000-0003-3922-7432
Observed ORCID:
0000-0003-3922-7432
OpenAlex ID:
A5008217392
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
2022
·
Koji Izutsu
, Shinichi Makita
, et al.
·
Blood
·
165
PDF
Clinicopathological and prognostic characteristics of CD56‐negative multiple myeloma
2002
·
Naohi Sahara
, Akihiro Takeshita
, et al.
·
British Journal of Haematology
·
146
The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia
2010
·
S. Nakamura
, I. Hirano
, et al.
·
Carcinogenesis
·
104
CMC‐544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B‐cell chronic lymphocytic leukaemia and lymphoma
2009
·
Akihiro Takeshita
, Kaori Shinjo
, et al.
·
British Journal of Haematology
·
68
Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial
2021
·
Kazunori Murai
, Hiroshi Ureshino
, et al.
·
The Lancet Haematology
·
63
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs
2015
·
T Narita
, A Inagaki
, et al.
·
Blood Cancer Journal
·
43
PDF
Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system
2019
·
the New TARGET investigators
, Masahiro Kizaki
, et al.
·
International Journal of Hematology
·
42
Expression of CD 56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts
2013
·
Takaaki Ono
, Akihiro Takeshita
, et al.
·
Cancer Science
·
41
PDF
CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells
2009
·
A Takeshita
, N Yamakage
, et al.
·
Leukemia
·
34
Which Tyrosine Kinase Inhibitors Should Be Selected as the First-Line Treatment for Chronic Myelogenous Leukemia in Chronic Phase?
2021
·
Takaaki Ono
·
Cancers
·
29
PDF
Long‐term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia
2012
·
Takaaki Ono
, Akihiro Takeshita
, et al.
·
Cancer Science
·
27
PDF
Clinicopathological and prognostic characteristics of CD33‐positive multiple myeloma
2006
·
Naohi Sahara
, Kazunori Ohnishi
, et al.
·
European Journal Of Haematology
·
26
Development and pharmacologic characterization of deoxybromophospha sugar derivatives with antileukemic activity
2009
·
Satoki Nakamura
, Mitsuji Yamashita
, et al.
·
Investigational New Drugs
·
25
Depletion of Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatases 1 and 2 by Bcr-Abl Promotes Chronic Myelogenous Leukemia Cell Proliferation through Continuous Phosphorylation of Akt Isoforms
2009
·
Isao Hirano
, Satoki Nakamura
, et al.
·
Journal of Biological Chemistry
·
25
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial
2017
·
Hirohisa Nakamae
, Tetsuya Fukuda
, et al.
·
International Journal of Hematology
·
24
KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells
2008
·
Satoki Nakamura
, Keiji Okinaka
, et al.
·
Leukemia Research
·
24
Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial
2018
·
Takashi Watanabe
, Kensei Tobinai
, et al.
·
The Lancet Haematology
·
22
Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia: 10-year results of the Japan Adult Leukemia Study Group APL97 study
2010
·
T. Ono
, A. Takeshita
, et al.
·
Haematologica
·
21
PDF
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study
2024
·
Itaru Matsumura
, Shigeki Ohtake
, et al.
·
Blood Advances
·
20
Severe neutropenia with gelatinous bone marrow transformation in anorexia nervosa: A case report
2003
·
Shinichiro Nishio
, Hiroshi Yamada
, et al.
·
International Journal of Eating Disorders
·
19
Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor
2020
·
Takaaki Ono
, Naoto Takahashi
, et al.
·
Cancer Science
·
18
PDF
Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation
2016
·
Yusuke Fukatsu
, Yasuyuki Nagata
, et al.
·
International Journal of Hematology
·
17
Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia
2020
·
Masayuki Hino
, Itaru Matsumura
, et al.
·
International Journal of Hematology
·
15
BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay
2011
·
Takaaki Ono
, Shuichi Miyawaki
, et al.
·
Leukemia Research
·
15
Nilotinib Vs. Dasatinib in Achieving MR4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212
2020
·
Itaru Matsumura
, Shigeki Ohtake
, et al.
·
Blood
·
14
Show more works
View as search
Works count:
132
Citation count:
1,319
H-index:
19
I10-index:
35
Year
Topic
Type
